Abbonarsi

Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy - 28/03/23

Doi : 10.1016/j.biopha.2023.114451 
Lianlian Fan a, 1, Anhui Wei b, 1, Zihui Gao c, Xupeng Mu d,
a Department of Pharmacy, China-Japan Union Hospital, Jilin University, Changchun130033, China 
b Department of Regenerative Medicine, College of Pharmacy, Jilin University, Changchun130021, China 
c Changchun City Experimental High School, Changchun130117, China 
d Scientific Research Center, China-Japan Union Hospital, Jilin University, Changchun130033, China 

Corresponding author.

Abstract

Nanodrug delivery systems have been widely used in disease treatment. However, weak drug targeting, easy to be cleared by the immune system, and low biocompatibility are great obstacles for drug delivery. As an important part of cell information transmission and behavior regulation, cell membrane can be used as drug coating material which represents a promising strategy and can overcome these limitations. Mesenchymal stem cell (MSC) membrane, as a new carrier, has the characteristics of active targeting and immune escape of MSC, and has broad application potential in tumor treatment, inflammatory disease, tissue regeneration and other fields. Here, we review recent progress on the use of MSC membrane-coated nanoparticles for therapy and drug delivery, aiming to provide guidance for the design and clinical application of membrane carrier in the future.

Il testo completo di questo articolo è disponibile in PDF.

Graphical Abstract




 : 

Mesenchymal stem cell (MSC) membrane, as a new carrier, has the characteristics of active targeting and immune escape of MSC, and has broad application potential in tumor treatment, inflammatory disease, and other fields. In this review, we provided a comprehensive overview of MSC membrane-coated nanoparticles, including its membrane coating methods and recent numerous biomedical applications.

Schematic illustration of MSC membranes engineered into NPs by various coating methods for biomedical applications. Some of the pictures adapted from [65,69].


Mesenchymal stem cell (MSC) membrane, as a new carrier, has the characteristics of active targeting and immune escape of MSC, and has broad application potential in tumor treatment, inflammatory disease, and other fields. In this review, we provided a comprehensive overview of MSC membrane-coated nanoparticles, including its membrane coating methods and recent numerous biomedical applications. Schematic illustration of MSC membranes engineered into NPs by various coating methods for biomedical applications. Some of the pictures adapted from [65,69]. ga1

Il testo completo di questo articolo è disponibile in PDF.

Highlights

MSC membrane has the characteristics of active targeting and immune escape of MSC.
MSC membrane-coated nanoparticles have broad applications for targeted therapy.
The MSC membrane coating technology and characterization need to be improved.
Membrane fusion with different properties can obtain better treatment effect.
MSC membrane-modified nanoparticles have challenges in clinical transformation.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : MSC, NPs, MPS, RBC, BMSCs, UMSCs, AMSCs, SDF-1, CXCR4, PDGF, VEGF, VCAM-1, VLA-4, MMP, DOX, SPIO, CuS, MOFs, TEM, SDS-PAGE, RGD, PDA, sgRNA, LSCs, PLGA, MI, PTEN, PDCD4, ITGB2, ICAM-1, MSN, KGN, STCM

Keywords : Mesenchymal stem cell, Nanotechnology, Drug delivery systems


Mappa


© 2023  The Authors. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 161

Articolo 114451- maggio 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Strategy and application of manipulating DCs chemotaxis in disease treatment and vaccine design
  • Yichao Lu, Jian You
| Articolo seguente Articolo seguente
  • The macrophage polarization in inflammatory dermatosis and its potential drug candidates
  • Qingru Sun, Shiyu Hu, Zhaohuan Lou, Jianli Gao

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.